First Trust Advisors LP Grifols Sa Transaction History

First Trust Advisors LP

  • $108 Billion
  • Q4 2024

A detailed history of First Trust Advisors LP transactions in Grifols Sa stock. As of the latest transaction made, First Trust Advisors LP holds 10,048 shares of GRFS stock, worth $77,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,048
Holding current value
$77,972
% of portfolio
0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$6.99 - $9.55 $70,235 - $95,958
10,048 New
10,048 $74,000
Q4 2023

Feb 13, 2024
BUY
$7.71 - $11.56 $2.33 Million - $3.5 Million
302,380 Added 6.9%
4,684,749 $54.2 Million
Q3 2023

Nov 13, 2023
SELL
$8.91 - $10.91 $18.4 Million - $22.6 Million
-2,067,420 Reduced 32.05%
4,382,369 $40.1 Million
Q2 2023

Aug 14, 2023
BUY
$7.14 - $9.29 $6.15 Million - $8 Million
861,168 Added 15.41%
6,449,789 $59.1 Million
Q1 2023

May 15, 2023
SELL
$6.65 - $10.69 $11 Million - $17.7 Million
-1,653,438 Reduced 22.83%
5,588,621 $41.2 Million
Q4 2022

Feb 09, 2023
BUY
$5.96 - $8.53 $17.1 Million - $24.5 Million
2,869,022 Added 65.61%
7,242,059 $61.6 Million
Q3 2022

Nov 14, 2022
SELL
$5.95 - $14.3 $684,850 - $1.65 Million
-115,101 Reduced 2.56%
4,373,037 $26.9 Million
Q2 2022

Aug 12, 2022
BUY
$10.6 - $13.28 $6.12 Million - $7.67 Million
577,763 Added 14.78%
4,488,138 $53.3 Million
Q1 2022

May 13, 2022
SELL
$10.37 - $12.73 $2.4 Million - $2.94 Million
-231,084 Reduced 5.58%
3,910,375 $45.7 Million
Q4 2021

Feb 08, 2022
BUY
$10.21 - $15.27 $2.4 Million - $3.59 Million
235,120 Added 6.02%
4,141,459 $46.5 Million
Q3 2021

Nov 15, 2021
BUY
$14.07 - $17.3 $6.47 Million - $7.96 Million
460,091 Added 13.35%
3,906,339 $57.1 Million
Q2 2021

Aug 16, 2021
SELL
$16.62 - $18.94 $4.12 Million - $4.7 Million
-248,107 Reduced 6.72%
3,446,248 $59.8 Million
Q1 2021

May 14, 2021
BUY
$15.15 - $19.78 $3.93 Million - $5.13 Million
259,477 Added 7.55%
3,694,355 $63.9 Million
Q4 2020

Feb 02, 2021
SELL
$16.86 - $19.67 $5.3 Million - $6.18 Million
-314,187 Reduced 8.38%
3,434,878 $63.3 Million
Q3 2020

Nov 05, 2020
BUY
$15.4 - $20.16 $9.7 Million - $12.7 Million
629,650 Added 20.18%
3,749,065 $65 Million
Q2 2020

Jul 22, 2020
BUY
$18.24 - $21.45 $13 Million - $15.2 Million
710,335 Added 29.49%
3,119,415 $56.9 Million
Q1 2020

May 06, 2020
SELL
$16.28 - $25.63 $656,995 - $1.03 Million
-40,356 Reduced 1.65%
2,409,080 $48.5 Million
Q4 2019

Feb 03, 2020
SELL
$19.57 - $23.52 $5.66 Million - $6.8 Million
-289,209 Reduced 10.56%
2,449,436 $57 Million
Q3 2019

Nov 04, 2019
SELL
$19.85 - $22.76 $46.4 Million - $53.2 Million
-2,335,265 Reduced 46.02%
2,738,645 $54.9 Million
Q2 2019

Jul 30, 2019
SELL
$17.59 - $21.1 $911,320 - $1.09 Million
-51,809 Reduced 1.01%
5,073,910 $107 Million
Q1 2019

May 09, 2019
BUY
$18.01 - $20.11 $8.16 Million - $9.11 Million
453,032 Added 9.7%
5,125,719 $103 Million
Q4 2018

Feb 07, 2019
BUY
$17.44 - $21.53 $661,638 - $816,805
37,938 Added 0.82%
4,672,687 $85.8 Million
Q3 2018

Oct 25, 2018
BUY
$19.97 - $21.96 $42.7 Million - $47 Million
2,139,441 Added 85.74%
4,634,749 $99 Million
Q2 2018

Aug 02, 2018
BUY
$20.16 - $24.68 $10.6 Million - $13 Million
527,595 Added 26.81%
2,495,308 $53.6 Million
Q1 2018

Apr 23, 2018
BUY
$20.31 - $24.95 $1.81 Million - $2.23 Million
89,312 Added 4.75%
1,967,713 $41.7 Million
Q4 2017

Feb 08, 2018
BUY
$20.99 - $23.89 $1.42 Million - $1.61 Million
67,501 Added 3.73%
1,878,401 $43.1 Million
Q3 2017

Oct 24, 2017
BUY
$20.07 - $21.89 $36.3 Million - $39.6 Million
1,810,900
1,810,900 $39.6 Million

Others Institutions Holding GRFS

# of Institutions
169
Shares Held
145M
Call Options Held
166K
Put Options Held
103K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.27B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email